SCHEMBL6809153

SCHEMBL6809153

Cc1ccc(C)c(COc2ccc(C[C]=O)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.42
MMP13 P45452 1/20 0.42
MAOB P27338 4/20 0.40
TAAR1 Q96RJ0 1/20 0.40
PARP10 Q53GL7 1/20 0.39
NPC1 O15118 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MAOA P21397 1/20 0.38
RAB9A P51151 1/20 0.38
ESR1 P03372 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
ESR2 Q92731 1/20 0.37
FFAR1 O14842 5/20 0.37
FFAR4 Q5NUL3 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970705 0.83 TDP1 (0.44) ADAMTS4MMP13MAOBTAAR1PARP10
SCHEMBL13929700 0.82 NPC1 (0.47) ADAMTS4MMP13MAOBTAAR1PARP10
SCHEMBL3970712 0.79 RAB9A (0.47) ADAMTS4MMP13MAOBNPC1TDP1
SCHEMBL6804913 0.78 PARP10 (0.56) MAOBPARP10MAPK1ALDH1A1MAPT
SCHEMBL3968418 0.76 TAAR1 (0.50) MAOBTAAR1TDP1L3MBTL1ALDH1A1
SCHEMBL3968416 0.76 TAAR1 (0.42) ADAMTS4MMP13MAOBTAAR1NPC1
SCHEMBL6628411 0.76 NPC1 (0.52) ADAMTS4MMP13MAOBPARP10NPC1
Hydrochloric Acid SCHEMBL6364077 0.75 TAAR1 (0.49) MAOBTAAR1TDP1L3MBTL1ALDH1A1
SCHEMBL1758599 0.75 TAAR1 (0.55) TAAR1NPC1TDP1ALDH1A1MAPT
SCHEMBL2089539 0.75 MAOB (0.68) MAOBL3MBTL1ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed
WO-2003016248-A2 BICYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$G(A) CONVERTING ENZYME (TACE) BRISTOL-MYERS SQUIBB COMPANY PATENT DEPARTMENT (US) 2003-02-27 WO disclosed